- Home
- MNPR vs BWB Comparison
MNPR vs BWB Comparison
Compare MNPR & BWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNPR | BWB |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 531.6M | 515.3M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MNPR | BWB |
|---|---|---|
| Price | $75.05 | $18.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $97.83 | $20.33 |
| AVG Volume (30 Days) | ★ 163.8K | 86.0K |
| Earning Date | 11-13-2025 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.72 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | ★ $127,243,000.00 |
| Revenue This Year | N/A | $35.67 |
| Revenue Next Year | N/A | $14.88 |
| P/E Ratio | ★ N/A | $14.21 |
| Revenue Growth | N/A | ★ 20.40 |
| 52 Week Low | $21.00 | $11.93 |
| 52 Week High | $105.00 | $18.87 |
Technical Indicators
Market Signals| Indicator | MNPR | BWB |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 71.73 |
| Support Level | $74.51 | $17.62 |
| Resistance Level | $79.31 | $18.16 |
| Average True Range (ATR) | 6.38 | 0.49 |
| MACD | -0.93 | 0.15 |
| Stochastic Oscillator | 6.10 | 97.47 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About BWB Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.